Clinical Trial: Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multicentre, Dose Optimisation Study to Assess the Consistency of Efficacy of Eletriptan for the Treatment of Migraine (With and Without Aura)
Brief Summary: Evaluation of headache response at 2 hours for active treated attacks for increasing dose.
Detailed Summary:
Sponsor: Pfizer
Current Primary Outcome: Consistency of headache response (3 responses out of 3 active treated attacks) . Headache response was defined as migraine headache pain of moderate or severe intensity pre dose becoming basent or mild within 2 hours post dose. [ Time Frame: 24 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Consistency of headache response (2 responses out of 3 active treated attacks). Headache response was defined as migraine headache pain of moderate or severe intensity pre dose becoming basent or mild within 2 hours post dose. [ Time Frame: 24 weeks ]
Original Secondary Outcome: Same as current
Information By: Pfizer
Dates:
Date Received: May 13, 2013
Date Started: March 2000
Date Completion:
Last Updated: May 17, 2013
Last Verified: May 2013